JY
ARA

Jeff Yass’s American Renal Associates Holdings, Inc ARA Stock Holding History

Jeff Yass’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,500
Closed -$104K – 11072
2019
Q3 		$104K Buy
+16,500
New +$123K ﹤0.01% 9544

Other funds holding ARA

CP
Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's ARA Position: Q4 2019 in Review

Jeff Yass sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2019, closing a stake of 11,938 shares — an estimated $102K sold.

Jeff Yass first reported a position in ARA in Q2 2019 and held it in 2 quarters. The position peaked at $100K in Q2 2019. 66 funds tracked by Wall St. Rank hold ARA as of Q4 2019.

  • Jeff Yass reported no remaining American Renal Associates Holdings, Inc position as of Q4 2019 after selling out during the quarter.
  • Jeff Yass sold 11,938 American Renal Associates Holdings, Inc shares in Q4 2019, an estimated $102K.
  • Jeff Yass first reported a position in American Renal Associates Holdings, Inc in Q2 2019 and held it in 2 quarters.
  • Jeff Yass's American Renal Associates Holdings, Inc position peaked at $100K in Q2 2019.
  • 66 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2019.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.